Qualigen Therapeutics Inc. will rebrand as AIxCrypto following a stockholder meeting on November 12, 2025. The company aims to expand the C10 Treasury to $50 million AUM and accelerate the global growth of the BesTrade DeAI Agent. AIxCrypto plans to launch crypto ecosystem tokens on leading exchanges, supported by potential stablecoins and dual-bridge products. Qualigen Therapeutics, Inc. is a biotechnology company based in Carlsbad, California, specializing in oncology and immunology therapies. The company is integrating crypto asset and Web3 strategies to accelerate global growth.

Read more at GlobeNewswire: Qualigen Therapeutics to Rebrand as AIxCrypto After